LAUREN HOLBROOK: Open Payments
NPI 1417515479 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$602 in 28 payments from 22 companies in 2025. Trend: 2023 $88 · 2024 $280 · 2025 $602
Food & beverage: $602
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $68 |
| Merck Sharp & Dohme LLC | 2 | $59 |
| Janssen Biotech, Inc. | 3 | $56 |
| Stemline Therapeutics Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Lilly USA, LLC | 1 | $29 |
| Celgene Corporation | 1 | $27 |
| BeOne Medicines USA, Inc. | 1 | $25 |
| Syndax Pharmaceuticals, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $24 |
Products named: Trodelvy, KEYTRUDA, TEVIMBRA, Orserdu, RYBREVANT, Nubeqa, RETEVMO, REBLOZYL.
Industry payments across TN — which companies pay providers there.
